Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Rendell

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Expert Review of Endocrinology & Metabolism|October 7, 2018
Report on the 2nd Annual Metabolic Diseases World SummitMarc Rendell
Expert Opinion on Pharmacotherapy|January 28, 2025
Pharmacotherapy of type 1 diabetes - part 1: yesterdayMarc Rendell
Drug Design, Development and Therapy|May 2, 2017
United States experience of insulin degludec alone or in combination for type 1 and type 2 diabetesMarc Rendell
Drugs|June 18, 2004
The role of sulphonylureas in the management of type 2 diabetes mellitusMarc Rendell
Expert Opinion on Investigational Drugs|March 11, 2024
Lessons learned from early-stage clinical trials for diabetic nephropathyMarc Rendell
Expert Opinion on Pharmacotherapy|June 11, 2026
The coming of weekly InsulinMarc Rendell
Expert Opinion on Pharmacotherapy|September 7, 2020
Pharmacotherapeutic options for prediabetesMarc Rendell
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: diabetes and cholesterolMarc Rendell
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: drug therapy of type 2 diabetesMarc Rendell
Expert Opinion on Drug Safety|February 12, 2013
The path to approval of new drugs for diabetesMarc Rendell
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Expert Review of Endocrinology & Metabolism|October 7, 2018
Report on the 2nd Annual Metabolic Diseases World SummitMarc Rendell
Expert Opinion on Pharmacotherapy|January 28, 2025
Pharmacotherapy of type 1 diabetes - part 1: yesterdayMarc Rendell
Drug Design, Development and Therapy|May 2, 2017
United States experience of insulin degludec alone or in combination for type 1 and type 2 diabetesMarc Rendell
Drugs|June 18, 2004
The role of sulphonylureas in the management of type 2 diabetes mellitusMarc Rendell
Expert Opinion on Investigational Drugs|March 11, 2024
Lessons learned from early-stage clinical trials for diabetic nephropathyMarc Rendell
Expert Opinion on Pharmacotherapy|June 11, 2026
The coming of weekly InsulinMarc Rendell
Expert Opinion on Pharmacotherapy|September 7, 2020
Pharmacotherapeutic options for prediabetesMarc Rendell
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: diabetes and cholesterolMarc Rendell
Medgenmed : Medscape General Medicine|January 14, 2005
Advances in diabetes for the millennium: drug therapy of type 2 diabetesMarc Rendell
Expert Opinion on Drug Safety|February 12, 2013
The path to approval of new drugs for diabetesMarc Rendell
Pageof 5